FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 
 

eCTD Validation Specifications

Validation is an important processing component in order to ensure compliance with the eCTD specification and improve the availability and reviewability of individual submissions and applications throughout their lifecycle. To facilitate the publication of guidance and specification compliant submissions, FDA is making available its current Validation Specifications

Specifications for eCTD Validation Criteria [PDF] PDF document (3/10/2008)

In addition to the validation criteria specified in this document, FDA may perform additional validation checks for both eCTD and non-eCTD submissions. These validation checks are intended to ensure that submissions are processed and routed accurately and in a timely fashion. The additional validation checks include:

  1. Ensuring that the application form submitted matches the application type specified in the us‑regional.xml file, e.g., the us‑regional.xml specified application type is NDA but the sponsor has submitted a 1571.
  2. Ensuring the consistency of the application number specified in the us‑regional.xml file and application form.

Additional information on submissions that do not pass the Agency’s validation checks may be found in Guidance for Industry Providing Regulatory Submissions in Electronic Format — Receipt Date [PDF] PDF document (Draft 6/4/2007)

to top arrow Back to Top     back arrow Back to eCTD

PDF document PDF requires the free Adobe Acrobat Reader

Date created: March 12, 2008

horizonal rule